Miravo Healthcare to launch Blexten in Canada

- Advertisement -

Ontario, Canada (CU)_ Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare, a Canada-based healthcare firm with global footprint and a diverse portfolio of commercial medicines, revealed the introduction of Blexten by its wholly owned branch, Aralez Pharmaceuticals Canada Inc. for pediatric patients aged 4 years and older.

Jesse Ledger, President & Chief Executive Officer of Miravo, expressed delight over the launch. He said, “Our sales force is excited to present our new Blexten formulations to the healthcare community. Blexten pediatric was approved by Health Canada in mid August 2021. The recent Canadian launch of the two new formats of Blexten, 10mg tablet and 2.5mg/mL oral solution for pediatric use, in addition to our existing 20mg tablet format available for patients 12 years of age and older, provides a single prescription antihistamine option for most Canadian allergy and urticaria patients”.

Timothy Vander Leek, MD, FRCPC, Clinical Immunologist & Allergist in Pediatrics Department at the Stollery Children’s Hospital in University of Alberta, expressed hopes over medicine. He said, “The introduction of Blexten pediatric with two new formats, orodispersible tablet (quick melt) and oral solution, gives us new prescription antihistamine options for allergy symptom control in children.”

aplususapharma

Dr. Jaggi Rao, MD, FRCPC (Dermatology) and Professor of Dermatology and Clinical Medicine at University of Alberta, expressed optimism over the launch of the new medicine. He said, “A new prescription strength antihistamine for children 4 years of age and over is a welcome addition to our treatment options for the hives and itching of chronic spontaneous urticaria.”

Blexten is a second-generation antihistamine medication used to treat allergic rhinitis and chronic spontaneous urticaria. Blexten works by inhibiting peripheral histamine H1 receptors with an effectiveness equivalent to cetirizine and desloratadine. Miravo is a Canadian-based healthcare firm with a global footprint and a diverse commercial product range. The company’s medicines are used to treat a variety of medical conditions, such as pain, allergies, neurology, and dermatology.

Hot this week

Fiji charts a bold path with new Investment strategies

Having previously been engaged in a regulatory model, Fiji...

Have We Come Too Far to Fall Back? World AIDS Day 2025 Exposes a Critical Crossroads

As the world marks World AIDS Day on 1...

Can Sri Lanka Survive Cyclone Ditwah’s Aftermath? Deaths Surge and Hundreds Remain Missing

A boat carrying people moves through a flooded street,...

How Will Canada Navigate the Costs of an Ageing Population? New Budget Leaves Key Questions Unanswered

Commonwealth_ Canada is undergoing a profound demographic shift, with...

Is Smart Public Funding the Missing Link in Scaling India’s Green Steel Dream?

(Commonwealth_India) India is standing at a critical moment in...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories

Commonwealth Union
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.